Trader consensus on the low likelihood of a new coronavirus pandemic in 2026 reflects sustained low-level SARS-CoV-2 circulation, with CDC data as of early August showing an Rt of 1.08, very low emergency department visits (0.2%), and no variants of concern meeting WHO criteria despite monitoring of lineages like BA.3.2. Global surveillance through wastewater sampling, genomic sequencing, and sentinel sites indicates stable activity without escalation in transmissibility, severity, or immune escape beyond endemic patterns. Updated 2025–2026 vaccines and integrated respiratory virus monitoring further support containment. A realistic challenge remains possible emergence of a novel coronavirus via zoonotic spillover or a highly divergent variant evading population immunity and causing widespread severe outcomes before detection.